65
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Immunological effects of AFM1 in experimental subchronic dosing in mice prevented by lactic acid bacteria

, , , , &
Pages 572-581 | Received 19 May 2020, Accepted 05 Sep 2020, Published online: 24 Sep 2020

References

  • Van Egmond HP. Mycotoxins in dairy products. London: Elsevier Applied Science; 1989.
  • Ferri F, Brera C, De Santis B, et al. Association between urinary levels of aflatoxin and consumption of food linked to maize or cow milk or dairy products. Int J Environ Res Public Health. 2020;17:2510.
  • Atanda O, Oguntubo A, Adejumo O, et al. Aflatoxin M1 contamination of milk and ice cream in Abeokuta and Odeda local governments of Ogun State, Nigeria. Chemosphere. 2007;68:1455–1458.
  • Nuryono N, Agus A, Wedhastri S, et al. A limited survey of aflatoxin M1 in milk from Indonesia by ELISA. Food Control. 2009;20:721–724.
  • Pecorelli I, Branciari R, Roila R, et al. Evaluation of Aflatoxin M1 enrichment factor in different cow milk cheese hardness category. Ital J Food Saf. 2020;9:8419–8429.
  • International Agency for Research on Cancer (IARC). Some naturally occurring substances, food items and constituents, heterocyclic aromatic amines and mycotoxins. 56. Lyon, France: World Health Organization; 1993. p. 489.
  • European Commission (EC). Commission Regulation. 1881/2006 of December 12th setting maximum levels of certain contaminants in foods. Off J Eur Commun L. 2006;364/5.
  • Abbès S, Salah-Abbès JB, Bouraoui Y, et al. Natural occurrence of aflatoxins (B1 and M1) in feed, plasma and raw milk of lactating dairy cows in Beja, Tunisia, using ELISA. Food Addit Contam B Surveill. 2012;5:11–15.
  • Turconi G, Guarcello M, Livieri C, et al. Evaluation of xenobiotics in human milk and ingestion by the newborn—an epidemiological survey in Lombardy (Northern Italy). Eur J Nutr. 2004;43:191–197.
  • Roda E, Coccini T, Acerbi D, et al. Comparative in vitro and ex-vivo myelotoxicity of aflatoxins B1 and M1 on haematopoietic progenitors (BFU-E, CFU-E, and CFU-GM): species-related susceptibility. Toxicol In Vitro. 2010;24:217–223.
  • Li H, Li S, Yang H, et al. l-Proline alleviates kidney injury caused by AFB1 and AFM1 through regulating excessive apoptosis of kidney cells. Toxins (Basel). 2019;11:226–226.
  • Assaf JC, Khoury AE, Chokr A, et al. A novel method for elimination of aflatoxin M1 in milk using Lactobacillus rhamnosus GG biofilm. Int J Dairy Technol. 2019;72:248–256.
  • Bodbodak S, Hesari J, Peighambardoust SH, et al. Selective decontamination of aflatoxin M1 in milk by molecularly imprinted polymer coated on the surface of stainless steel plate. Int J Dairy Technol. 2018;71:868–878.
  • Sander B, Höidén I, Andersson U, et al. Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. J Immunol Methods. 1993;166:201–214.
  • Kisaki T, Kobayashi S, Ogasawra K, et al. Immune suppression induced by protoscoleces of E. multilocularis in mice. Evidence for the presence of CD8 dull suppressor cells in spleens of mice intraperitoneally infected with E. multilocularis. J Immunol. 1991;147:1659–1663.
  • Ben Salah-Abbès J, Jebali R, Sharafi H, et al. Immuno-physiological alterations from AFB1 in rats counteracted by treatments with Lactobacillus paracasei BEJ01 and montmorillonite clay mixture. J Immunotoxicol. 2016;13:628–637.
  • Kabak B, Var I. Factors affecting the removal of aflatoxin M1 from food model by Lactobacillus and Bifidobacterium strains. J Environ Sci Health B. 2008;43:617–624.
  • Mogilnaya OA, Puzyr AP, Bondar VS. Growth and bioluminescence of luminous bacteria under the action of aflatoxin B1 before and after its treatment with nanodiamonds. Appl Biochem Microbiol. 2010;46:33–37.
  • El-Nezami H, Kankaanpaa P, Salminen S, et al. Ability of dairy strains of lactic acid bacteria to bind a common food carcinogen, aflatoxin B1. Food Chem Toxicol. 1998;36:321–326.
  • Khadivi R, Razavilar V, Anvar A, et al. Aflatoxin M1-binding ability of selected lactic acid bacteria strains and Saccharomyces boulardii in the experimentally contaminated milk treated with some biophysical factors. Arch Razi Inst. 2020;75:63–73.
  • Var I, Kabak B. Removal of aflatoxins by viable and heat-killed lactic acid bacteria and bifidobacteria. Arch Lebensmittelhyg. 2004;55:106–109.
  • Pierides M, El-Nezami H, Peltonen K, et al. Ability of dairy strains of lactic acid bacteria to bind aflatoxin M1 in a food model. J Food Prot. 2000;63:645–650.
  • Sarımehmetoglu B, Kuplulu O. Binding ability of aflatoxin M1 to yoghurt bacteria. Ankara Univ Vet Fak Dergisi. 2004;51:195–198.
  • Brackett RE, Marth EH. Association of aflatoxin M1 with casein. Z Lebensm Unters Forsch. 1982;174:439–441.
  • Ben Salah-Abbès J, Abbès S, Jebali R, et al. Potential preventive role of lactic acid bacteria against aflatoxin M1 immunotoxicity and genotoxicity in mice. J Immunotoxicol. 2015;12:107–114.
  • Abbès S, Ben Salah-Abbès J, Sharafi H, et al. Lactobacillus paracasei BEJ01 prevents immunotoxic effects during chronic zearalenone exposure in Balb/c mice. Immunopharmacol Immunotoxicol. 2013;35:341–348.
  • Abbès S, Salah-Abbès JB, Sharafi H, et al. Ability of Lactobacillus rhamnosus GAF01 to remove AFM1 in vitro and to counteract AFM1 immunotoxicity in vivo. J Immunotoxicol. 2013;10:279–286.
  • Jebali R, Abbès S, Salah-Abbès JB, et al. Ability of Lactobacillus plantarum MON03 to mitigate aflatoxins (B1 and M1) immunotoxicities in mice. J Immunotoxicol. 2015;12:290–299.
  • Nurul A, Liew Z, Mohd WP, et al. Effect of high protein diet and probiotic Lactobacillus casei Shirota supplementation in aflatoxin B1-induced rats. Biomed Res Int. 2018;2018:1–356.
  • Theumer MG, López AG, Masih DT, et al. Immunobiological effects of AFB1 and AFB1-FB1 mixture in experimental subchronic mycotoxicoses in rats. Toxicology. 2003;186:159–170.
  • Griffiths BB, Rea WJ, Johnson AR, et al. Mitogenic effects of mycotoxins on T4 lymphocytes. Microbios. 1996;86:127–134.
  • Raisuddin S, Singh KP, Zaidi SI, et al. Immunosuppressive effects of aflatoxin in growing rats. Mycopathologia. 1993;124:189–194.
  • Shirani K, Zanjani BR, Mahmoudi M, et al. Immunotoxicity of aflatoxin M1: as a potent suppressor of innate and acquired immune systems in a subacute study. J Sci Food Agric. 2018;98:5884–5892.
  • Martinova EA. Influence of sphingolipids on T lymphocyte activation. Biochemistry (Mosc). 1997;63:102–110.
  • Bao XY, Li SL, Gao YN, et al. Transcriptome analysis revealed that aflatoxin M1 could cause cell cycle arrest in differentiated Caco-2 cells. Toxicol In Vitro. 2019;59:35–43.
  • Arai K, Lee F, Miyajima A, et al. Cytokines: co-ordinators of immune and inflammatory responses. Annu Rev Biochem. 1990;59:783–836.
  • Luongo D, Russo R, Balestrieri A, et al. In vitro study of AFB1 and AFM1 effects on human lymphoblastoid Jurkat T-cell model. J Immunotoxicol. 2014;11:353–358.
  • Chen WF, Zlotnik A. IL-10: a novel cytotoxic T cell differentiation factor. J Immunol. 1991;147:528–534.
  • Bianco G, Russo R, Marzocco S, et al. Modulation of macrophage activity by aflatoxins B1 and B2 and their metabolites aflatoxins M1 and M2. Toxicon. 2012;59:644–650.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.